Akbari Vajihe, Rezazadeh Mahboubeh, Minayian Mohsen, Amirian Marjan, Moghadas Azadeh, Talebi Ardeshir
Department of Pharmaceutical Biotechnology and Isfahan Pharmaceutical Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran.
Department of Pharmaceutics and Novel Drug Delivery System Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran.
Res Pharm Sci. 2018 Dec;13(6):476-483. doi: 10.4103/1735-5362.245959.
Erythropoietin (EPO) was successfully incorporated into a bioadhesive thermosensitive hydrogel based on trimethyl chitosan (TMC)/β-glycerophosphate (GP) for prevention and treatment of oral mucositis in cancerous patients. The aim of the present study was to evaluate the effect of freeze drying on thermo-responsive property of the hydrogel and structural stability of the loaded protein. The freeze-dried EPO-loaded hydrogel were characterized using various methods. Gelation property by rheological analysis, EPO aggregation in formulations by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), protein secondary structure by far ultraviolet-circular dichroism (CD), and the antigenic activity of EPO with ELISA techniques. The healing effects of the freeze-dried formulation was also investigated in Sprague-Dawley rats with chemotherapy-induced mucositis and compared with freshly prepared mixture. Finally, the retention time of the gel in the oral cavity was assessed in healthy volunteers. SDS-PAGE, CD, and ELISA confirmed the stability of conformational structure of loaded and released EPO. Severity of mucositis was markedly reduced in animals treated with freeze-dried EPO hydrogel; whereas the group received normal saline did not show any significant healing. EPO salvia level was decreased rapidly following EPO solution compared to the gel application. Approximately, 40% of EPO was maintained on the buccal areas in patients receiving the hydrogel system after 30 min. Therefore, the TMC/GP could preserve EPO stability after freeze drying and has the potential in the treatment of oral mucositis and other oral or subcutaneous wounds.
促红细胞生成素(EPO)已成功被载入基于三甲基壳聚糖(TMC)/β-甘油磷酸酯(GP)的生物黏附热敏水凝胶中,用于预防和治疗癌症患者的口腔黏膜炎。本研究的目的是评估冷冻干燥对水凝胶热响应特性和所载蛋白质结构稳定性的影响。采用多种方法对冻干的载EPO水凝胶进行了表征。通过流变学分析测定凝胶化特性,通过十二烷基硫酸钠聚丙烯酰胺凝胶电泳(SDS-PAGE)测定制剂中EPO的聚集情况,通过远紫外圆二色性(CD)测定蛋白质二级结构,并采用酶联免疫吸附测定(ELISA)技术测定EPO的抗原活性。还在化疗诱导的黏膜炎的Sprague-Dawley大鼠中研究了冻干制剂的愈合效果,并与新制备的混合物进行比较。最后,在健康志愿者中评估了凝胶在口腔中的保留时间。SDS-PAGE、CD和ELISA证实了所载和释放的EPO构象结构的稳定性。用冻干的EPO水凝胶治疗的动物中黏膜炎的严重程度明显降低;而接受生理盐水的组未显示任何明显的愈合情况。与应用凝胶相比,EPO溶液给药后EPO在唾液中的水平迅速下降。接受水凝胶系统的患者在30分钟后,约40%的EPO保留在颊部区域。因此,TMC/GP在冷冻干燥后可保持EPO的稳定性,在治疗口腔黏膜炎及其他口腔或皮下伤口方面具有潜力。